BR112013011167A2 - "exame de suplementos eficientes e efetivos para o desenvolvimento de meio quimicamente definido em cultura de células." - Google Patents

"exame de suplementos eficientes e efetivos para o desenvolvimento de meio quimicamente definido em cultura de células."

Info

Publication number
BR112013011167A2
BR112013011167A2 BR112013011167A BR112013011167A BR112013011167A2 BR 112013011167 A2 BR112013011167 A2 BR 112013011167A2 BR 112013011167 A BR112013011167 A BR 112013011167A BR 112013011167 A BR112013011167 A BR 112013011167A BR 112013011167 A2 BR112013011167 A2 BR 112013011167A2
Authority
BR
Brazil
Prior art keywords
cell culture
chemically defined
supplements
examination
efficient
Prior art date
Application number
BR112013011167A
Other languages
English (en)
Inventor
Christopher Racicot
John C Fann
Patrick Hossler
Sean Mcdermott
Original Assignee
Abbvie Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbvie Inc filed Critical Abbvie Inc
Publication of BR112013011167A2 publication Critical patent/BR112013011167A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing

Abstract

exame de suplementos eficientes e efetivos para o desenvolvimento de meio quimicamente definido em cultura de células. a presente invenção refere-se aos métodos de selecionar e desenvolver um meio quimicamente definido ("cdm") para uso na manufatura de produtos biológicos. em particular, a presente invenção é dirigida aos métodos de exame para determinar as combinações de suplementos do meio de técnica de cultura de células com características de desempenho aumentadas. a presente invenção é também dirigida a identificar combinações de suplementos de cdm que demonstrem aumentos significativos no título de coleta e/ou na densidade de células viáveis.
BR112013011167A 2010-11-05 2011-11-04 "exame de suplementos eficientes e efetivos para o desenvolvimento de meio quimicamente definido em cultura de células." BR112013011167A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41070910P 2010-11-05 2010-11-05
PCT/US2011/059263 WO2012078270A2 (en) 2010-11-05 2011-11-04 Efficient and effective supplement screening for the development of chemically defined media in cell culture

Publications (1)

Publication Number Publication Date
BR112013011167A2 true BR112013011167A2 (pt) 2016-08-23

Family

ID=45048211

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013011167A BR112013011167A2 (pt) 2010-11-05 2011-11-04 "exame de suplementos eficientes e efetivos para o desenvolvimento de meio quimicamente definido em cultura de células."

Country Status (13)

Country Link
US (1) US9068970B2 (pt)
EP (1) EP2635905A2 (pt)
JP (1) JP2013542736A (pt)
KR (1) KR20130118899A (pt)
CN (1) CN103270416A (pt)
AU (1) AU2011338892A1 (pt)
BR (1) BR112013011167A2 (pt)
CA (1) CA2815933A1 (pt)
MX (1) MX2013005058A (pt)
RU (1) RU2013125777A (pt)
SG (1) SG190129A1 (pt)
TW (1) TW201300535A (pt)
WO (1) WO2012078270A2 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2841822C (en) 2011-07-12 2016-08-16 Foodchek Systems Inc. Culture medium, method for culturing salmonella and e. coli and method for detecting salmonella and e. coli
WO2014145098A1 (en) * 2013-03-15 2014-09-18 Genentech, Inc. Cell culture compositions with antioxidants and methods for polypeptide production
CN106318998B (zh) * 2015-07-08 2019-08-20 浙江海正博锐生物制药有限公司 用于提高重组人ⅱ型肿瘤坏死因子受体-抗体融合蛋白唾液酸化水平的组合物
TWI797060B (zh) * 2015-08-04 2023-04-01 美商再生元醫藥公司 補充牛磺酸之細胞培養基及用法
US20180355304A1 (en) * 2015-12-03 2018-12-13 Merck Patent Gmbh Chemically defined media for the growth or detection of microorganisms
US10119117B2 (en) * 2016-01-28 2018-11-06 Nanogen Pharmaceutical Biotechnology Co., Ltd Universal, glycosylation enhancer, completely chemically defined medium formulation
EP3511367A4 (en) * 2016-09-09 2019-09-18 Asahi Kasei Pax Corporation FOIL, FILM ROLL, FILM STORAGE CONTAINER AND METHOD FOR PROTECTING THE CONTAINER IN WHICH THE FOIL IS USED
CN106434532A (zh) * 2016-12-22 2017-02-22 叶宗耀 一种培养肝细胞的培养基及其制备方法
CN108314193B (zh) * 2018-01-27 2020-06-09 中国科学院成都生物研究所 一种提高清洗剂废水低温微生物处理效果的激活促进剂
WO2021078938A1 (en) * 2019-10-25 2021-04-29 Fundació Centre De Regulació Genòmica Culture media for mycoplasma
CN115369069B (zh) * 2022-08-22 2023-12-19 上海健士拜生物科技有限公司 293细胞补料培养基及其制备和应用
CN115505561A (zh) * 2022-11-24 2022-12-23 天信和(苏州)生物科技有限公司 一种用于cho细胞的无血清培养基添加剂及其用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD266710A3 (de) 1983-06-06 1989-04-12 Ve Forschungszentrum Biotechnologie Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase
US4879231A (en) 1984-10-30 1989-11-07 Phillips Petroleum Company Transformation of yeasts of the genus pichia
GB8610600D0 (en) 1986-04-30 1986-06-04 Novo Industri As Transformation of trichoderma
EP0402226A1 (en) 1989-06-06 1990-12-12 Institut National De La Recherche Agronomique Transformation vectors for yeast yarrowia
US6387651B1 (en) * 1995-04-12 2002-05-14 Biolog, Inc. Comparative phenotype analysis of two or more microorganisms using a plurality of substrates within a microwell device
US7009180B2 (en) * 2001-12-14 2006-03-07 Optiscan Biomedical Corp. Pathlength-independent methods for optically determining material composition
CN100355880C (zh) * 2004-11-19 2007-12-19 上海中科伍佰豪生物工程有限公司 高通量哺乳动物细胞培养基优化方法

Also Published As

Publication number Publication date
AU2011338892A1 (en) 2013-05-23
SG190129A1 (en) 2013-06-28
US9068970B2 (en) 2015-06-30
JP2013542736A (ja) 2013-11-28
CN103270416A (zh) 2013-08-28
RU2013125777A (ru) 2014-12-10
EP2635905A2 (en) 2013-09-11
WO2012078270A2 (en) 2012-06-14
KR20130118899A (ko) 2013-10-30
CA2815933A1 (en) 2012-06-14
US20120129727A1 (en) 2012-05-24
TW201300535A (zh) 2013-01-01
MX2013005058A (es) 2013-06-28
WO2012078270A3 (en) 2012-08-23

Similar Documents

Publication Publication Date Title
BR112013011167A2 (pt) "exame de suplementos eficientes e efetivos para o desenvolvimento de meio quimicamente definido em cultura de células."
CL2008002085A1 (es) Anticuerpo humanizado anti-cd79b/igbeta/b29; polinucleotido codificacnte, vector, celula huesped; metodo de fabricacion; inmunoconjugado; composicion farmaceutica; uso para tratar cancer; metodo in vitro para determinar presencia de cd79b, oinhibir crecimiento de celulas quqe expresa cd79b; ensayo in vitro para detectar celulas b
BR112012030788A2 (pt) métodos de detecção de anticorpos monoclonais para enzimas que conferem resistência ao ácido 2,4-diclorofenoxiacético em plantas
CL2008000604A1 (es) Proceso para separacion magnetica de particulas magneticas o susceptibles de ser magnetizadas que comprende contactar la sustancia con materiales solidos magneticos, susceptibles de ser magnetizados, no magneticos o no susceptibles de ser magnetizado
BR112014004543A2 (pt) método de síntese de proteínas
RS53496B1 (en) PROCEDURE FOR THE DETECTION OF Aβ-SPECIFIC ANTIBODIES IN A BIOLOGICAL SAMPLE
BRPI0802385A2 (pt) um produto seqÜestrante de hidrocarbonetos, mÉtodo para a obtenÇço do produto, mÉtodo para o seqÜestro de hidrocarbonetos e disposiÇço para o seqÜestro de hidrocarbonetos
BR112013005247A2 (pt) sistemas e métodos para análise de documentos
BRPI1014141B1 (pt) método e meio de cultura para detecção aumentada de micobactéria
Knudsen et al. VizieR Online Data Catalog: Submm observations in gravitational lenses (Knudsen+, 2008)
Elling Factors controlling the lipid composition of marine planktonic Thaumarchaeota
Murono Virus-associated biomarkers in oropharyngeal and nasopharyngeal cancers and recurrent respiratory papillomatosis
CL2011001453A1 (es) Metodo para identificar un anticuerpo o fragmento del mismo de union a antigeno expresado en una celula, particulamente una celula b, que se une especificamente a un antigeno de interes de la superficie celular.
Fadhel Toxoplasmosis disease and its association with hepatic enzymes
Kohnert et al. Geogenic sources strongly contribute to the Mackenzie River Delta's methane emissions derived from airborne flux data
Hilliard et al. A Novel Transparent Sediment Simulant for Unveiling the Bed Topography and Interstitial Processes
Furukawa et al. Genotypic Characterization of Enterococci Collected from a Coastal Area Using PFGE
Xie Organic-geochemical studies of microbial lipids and carbon flow in oxygen-deficient marine environments
Osorio et al. Integrating the GLORIA sampling design into British Columbia's Biogeoclimatic Ecosystem Classification system.
Chu et al. Fostering the culture of reading and enhancing information literacy: exemplars of school libraries
Zhou Study of the compilation and technical analysis of container freight index based on EDI.
Kim et al. Characterization of a high pressure, chemical ionization time-of-flight mass spectrometer for the measurement of alkylamines in the marine boundary layer
Harris et al. Linking Wave Forcing to Coral Cover and Structural Complexity Across Coral Reef Flats
Martin et al. Sections of Intact Polar Diacylglycerolipids in the South Atlantic Reflect Dissolved Phosphorus and Nitrogen Distributions
Pétron et al. What measurements tell us about air composition and emissions in three US oil and gas fields

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2386 DE 27-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]